On March 13, the ‘X-Men: Apocalypse’ star posted at length on Instagram about being diagnosed with Luminal B cancer with hopes of spreading awareness on this fast-growing form of breast cancer
This week, actress Olivia Munn made headlines on the news of her breast cancer diagnosis. According to her lengthy Instagram post on March 13, the X-Men: Apocalypse and The Daily Show with Jon Stewart star revealed her decision to be proactive about her health in February 2023, when she took a genetic test checking for 90 types of cancer genes, including the BRCA gene. Testing negative for the test, she wrote that she also had a normal mammogram that winter.
See also: Breast Cancer Researcher Shivaani Mariapun Wants To Empower Women
It was only two months later that she discovered she had Luminal B cancer in both her breasts, an aggressive and fast-growing form of breast cancer. “I wouldn’t have found my cancer for another year–at my next scheduled mammogram,“ she wrote in the Instagram post. “Except that my obgyn, Dr Thais Aliabadi, decided to calculate by Breast Cancer Risk Assessment Score. The fact that she did saved my life.”
Following her diagnosis, Munn underwent a total of four surgeries over ten months, including a double mastectomy just 30 days after her biopsy. “I’m lucky. We caught it with enough time that I had options.” she wrote. “I want the same for any woman who might have to face this one day.”
Munn didn’t hesitate to thank her “guardian angel”, Dr Thais Aliabadi, as well as her breast reconstructive surgeon and other members of the medical team at the LA hospital Cedars-Sinai and at St John’s Health Centre in Santa Monica.
All this time, Munn kept the news of her diagnosis and surgeries private until this week, taking the time to process the life changes following her treatments and also share her story for the benefit of other women in similar situations. According to the Mayo Clinic, using genetic information about breast cancer cells is an approach used increasingly by doctors to categorise breast cancers and determine the most effective, targeted plans for treatment.